scorecardresearch
Tuesday, July 22, 2025
TopicPfizer

Topic: Pfizer

Covid pandemic: ‘Bizarre’ offer to tarnish Pfizer in France, win lottery for vaccine in Poland

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe

Pfizer shot after AstraZeneca is safe, could induce better immune response, researchers find

India isn’t looking at a mixing option just yet as Pfizer is unavailable in the country so far and there is no data on mixing Covaxin and Covishield.

Delay in giving second shot of Pfizer vaccine boosts immune response in elderly: Study

The study, led by the University of Birmingham in collaboration with Public Health England, found that extending the 2nd dose interval to 12 weeks increases antibody response 3.5-fold.

59% Americans support waiving patents for Covid vaccines and life-saving drugs, survey shows

The poll also revealed that a majority of US voters want pharma giant Moderna to share the technology of its taxpayer-funded vaccine.

Canada becomes first country to approve Pfizer Covid vaccine for adolescents

Canada's decision comes ahead of a similar clearance that is expected soon from regulators in the US. The vaccine was initially approved in December 2020 for those 16 and older.

Covid-19 pandemic: Indonesian firm reuses nasal swabs, Pfizer seeks to vaccinate 2-yr-olds

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

Discussions on with Indian govt for expedited approval of Pfizer Covid vaccine, says CEO

Pfizer is aware that access to vaccines is critical. Unfortunately, our vaccine is not registered in India although our application was submitted months ago, the CEO added.

Pfizer booster shot ‘likely’ needed within 1 year, says CEO

Pfizer's CEO Albert Bourla said the six months of data shows ‘extremely, extremely high’ protection from Covid-19, noting that protection still ‘goes down by time.’

Modi govt wants more Covid vaccines, but Moderna is ‘not keen’ & Pfizer has this ‘condition’

CSIR has been in talks with Moderna for around 6 months but the company hasn't shown much interest. Pfizer will reassess Modi govt's latest stance on indemnifying vaccine makers.

Pfizer’s Covid shot remains more than 91% effective even after 6 months, trial finds

The six-month result is only slightly lower than the 95% efficacy rate that was originally found for the vaccine, based on much shorter term results.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.